A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

First Patient Treated with Coronet Soft Tissue Fixation System

October 20, 2020

The first patient treated with Coronet Soft Tissue Fixation System was announced today by CoNextions Inc. Coronet Soft Tissue Fixation System in a Kidner procedure. The Kidner procedure is the most common surgical treatment for a painful accessory navicular bone that causes foot/tendon pain.

The Coronet Soft Tissue Fixation Systems is a tenodesis device intended for the fixation of soft tissue and tendon to bone.  During the Kidner procedure, a surgeon detaches the posterior tibial tendon from the bone and removes the pain-causing bone from the foot.  The posterior tibial tendon is then reattached to the navicular bone and secured with the Coronet.

Coronet’s novel design improves the soft tissue fixation strength of these repairs compared to conventional suture modalities.  A streamlined delivery system allows for the simultaneous placement of the implant in the bone and soft tissue and provides a knotless repair.  The Coronet is cleared for use by the FDA for the fixation of soft tissue to bone and tissue to tissue throughout numerous anatomical locations.  The first patient was treated by Youngstown, Ohio foot and ankle surgeon, Dr. Lawrence DiDomenico, at The Surgical Hospital at Southwoods.

“The Coronet was remarkably effective in streamlining the posterior tibial tendon reattachment portion of the Kidner procedure,” said Dr. DiDomenico.  “I am excited at the time efficiency the Coronet provided by not having to suture.  I also appreciate the ease of obtaining the appropriate tension with the Coronet versus suture.”

CoNextions Medical is currently launching the Coronet throughout the United States.  The device will be marketed by a network of orthopedic distributors across the country.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy